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Abstract
Background: Many developing countries are experiencing the epidemiological transition, with the majority of
deaths attributed to cardiovascular disease, cancer, Type 2 diabetes (T2DM) and others. In some countries, large
proportional mortality attributed to diabetes is evident in official mortality statistics, with Mauritius and Fiji rated as the
highest in the world.
Methods: This study investigates trends in recorded diabetes and cardiovascular disease mortality in Mauritius and
Fiji under coding from the International Classification of Diseases (ICD) versions 9 and 10, using mortality data
reported from these countries to the World Health Organization (WHO).
Results: In Mauritius over 1981–2004, T2DM proportional mortality varied between 4% and 7% in males (M) and 5%
and 9% in females (F). In 2005 there was a sudden increase to M 20% and F 25%, which continued to M 25% and F
30% by 2012. Over 1981–2004 the proportion of circulatory disease mortality rose from 44% to 49% in males, and from
46% to 57% in females. In 2005, circulatory disease mortality proportions fell precipitously to 34% in males and 37% in
females, and declined to 31% and 34% by 2013. ICD–10 coding was introduced in 2005.
In Fiji, sharp rises in proportional T2DMmortality from 3% in both sexes in 2001 to M 15% and F 20% in 2002 were
followed by more gradual trend increases to M 20% and F 26% by 2012–13. Circulatory disease proportions fell steeply
from M 57% and F 53% in 2001 to M 44% and M 38% by 2004, with subsequent less steep declines to M 39% and F
30% by 2012. ICD–10 coding was introduced in 2001.
Conclusions: Large, abrupt changes in diabetes and circulatory disease proportional mortality in Fiji and Mauritius
coincided with the local introduction of ICD–10 coding in different years. There is also evidence for diabetes-related
misclassification of underlying cause of death in Australia and the USA. These artefacts can undermine accurate
monitoring of cause of death for evaluation of effectiveness of prevention and control, especially of circulatory disease
mortality which is demonstrably reversible in populations.
Keywords: Diabetes, Mortality, Cardiovascular disease, Trends, ICD coding
*Correspondence: s.morrell@unsw.edu.au
1School of Public Health and Community Medicine (SPHCM), Faculty of
Medicine University of New South Wales (UNSW), Sydney, Australia
Full list of author information is available at the end of the article
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Morrell et al. BMC Public Health          (2019) 19:481 Page 2 of 9
Background
Accurate magnitude and secular trends of mortality by
cause are important for monitoring population effects of
possible causative influences, and effectiveness of preven-
tion and control measures. Various international sources
indicate considerable variability in rates and proportions
of diabetes mortality derived from official country mor-
tality statistics. The WHO reports diabetes mortality for
2012 (age standardised, both sexes) as 175/105for Mau-
ritius, [1] close to the estimate of 174/105 shown on the
World Life Expectancy website [2]. For Fiji, WHO indi-
cates diabetes mortality as 160/105, [1] and the World
Life Expectancy website estimates it as 147/105. Mauritius
and Fiji are ranked by the World Life Expectancy web-
site as having the two highest diabetes mortality rates in
the world [2]. The Institute for Health Metrics and Eval-
uation Global Burden of Disease (IHME GBD) estimates
for 2015 indicate that diabetes is ranked first or second
in years of life lost (YLL) in Mauritius and Fiji, depend-
ing on the combination or disaggregation of categories of
cardiovascular disease.
A number of ‘bridge-coding’ studies have estimated
changes in cause-specific mortality trends attributable to
changeovers from ICD–9 to ICD–10 cause-of-death cod-
ing, including in the US, [3] and Europe [4–7]. The US
study attributed a < 1% rise in mortality from diabetes
complications to the coding changeover, [3] while a Euro-
pean study reported no significant changes in Norway,
Sweden and Finland, but a 20% diabetesmortality increase
in the Netherlands [4]. For cerebrovascular disease, the
US study found a 6% increase attributable mostly to the
ICD–10 rule change in classifying pneumonia (frequently
an immediate terminal condition) as cerebrovascular dis-
ease if both are present on the death certificate; and a
2% decline in ‘heart conditions’ (ICD–10 codes I00–I09,
I11, I13, I20–I51) due mainly to cardiac arrest being non-
specific (and also likely immediately terminal), and clas-
sified as diabetes if diabetes is also present on the death
certificate. While artefactual changes of these magnitudes
would be expected to accompany changes to coding sys-
tems and rules, assessment of mortality changes accompa-
nying coding changes may not be occurring in less devel-
oped countries. Despite extensive literature searches, the
authors were not able to locate studies of mortality trends
in developing countries in relation to cause-of-death cod-
ing changes.
Diabetes can result in specific diabetes-related compli-
cations, especially metabolic abnormalities (ketoacidosis,
hyperosmolar states), renal disease and insufficiency, gan-
grene of the extremities, retinopathy and blindness, neu-
ropathy, and others, as listed in successive editions of the
ICD coding system, [8] several of which can lead directly
to death. Along with blood pressure, blood lipid levels,
and tobacco smoking, diabetes is also a risk factor for
atherosclerotic cardiovascular disease which is a major
cause of death in diabetics. Death from atherosclerotic
coronary or cerebrovascular disease, with or without dia-
betes as a risk factor, is classified under circulatory disease
as the underlying cause of death. There are no ICD codes
under diabetes for these conditions. Diabetes without fatal
diabetes-specific complications does not directly cause
death, but can contribute to death, especially from car-
diovascular disease. When a contributing risk factor for
death, uncomplicated diabetes should be placed in Part II
of the death certificate, the section reserved for contribut-
ing risk factors for death from a given cause.
Tabulation of publicly available WHO mortality data
supplied by countries indicates a relatively high propor-
tion of deaths attributable to diabetes in Mauritius and
Fiji compared to other countries according to the latest
available data [9]. We hypothesised that these proportions
may be artefactual and possibly related to mortality cod-
ing changes, from ICD–9 to ICD–10. In the present study,
secular trends in diabetes deaths are compared to trends
in cardiovascular disease mortality in Mauritius and Fiji,
and in relation to ICD versions used for derivation and
coding of underlying cause of death. Secular trends in
the same causes of death in Australia are provided for
comparison.
Methods
Data sources
WHO mortality data were analysed by trends in pro-
portional contributions of diabetes as underlying cause
to total deaths using ICD–9 and ICD–10 codes for dia-
betes from ICD–9 Chapter 3 (‘Endocrine, Nutritional and
Metabolic Diseases, and Immunity Disorders’) and ICD–
10 Chapter IV (‘Endocrine, nutritional and metabolic dis-
eases’). Contributions of circulatory disease were assessed
from ICD–9 Chapter 7 and ICD–10 Chapter IX, ‘Diseases
of the Circulatory System’, as underlying cause of death
to overall (all-cause) mortality. These data are available
by single year, sex and 5–year age group, with the cor-
responding ICD coding version varying across countries
[10]. WHO mortality supplied by individual countries are
coded according to the edition of ICD in use at the time
of mortality registration in each country. These data are
freely and publicly available at the WHO website [10].
For Mauritius, WHO mortality data spans 1981–2016.
For Fiji, WHO annual death data from 2001 to 2012 are
analysed. Although 1999 Fiji data are available fromWHO
for Fiji, 2000 data aremissing, and there are significant and
implausible differences in cause structure between 1999
and 2001, so 1999 data are not included in analyses. Mor-
tality data were accessed from the most recently updated
WHOmortality data available in April 2018. Correspond-
ing data for Australia covering 1980–2015 are also plotted
for comparison.
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Study design and analysis
Differences in population trends in proportions of dia-
betes and circulatory disease as underlying cause of death
of total (all cause) mortality are plotted over time in rela-
tion to changes from ICD–9 to ICD–10 mortality coding.
SAS version 9.4 was used for data extraction, calcula-
tion of proportions and exact binomial 95% confidence
intervals, and for plotting trends.
Results
Proportional circulatory disease mortality over 1980–
2015 in Australia has shown steady declines, from 57% in
males and 49% in females in 1980, to 31% and 28%, respec-
tively by 2015 (Fig. 1). Diabetes proportional mortality has
increased steadily over the corresponding period, from
2% to 4% of all mortality. No significant interruption to
these trends is associated with the 1998 changeover from
ICD–9 to ICD–10 coded mortality as reported to WHO.
In Mauritius over 1981–2004, diabetes proportional
mortality showed no substantial trend, varying between
2–7% for males, and 3–9% in females. In 2005 there was
a sudden increase to 20% in males and 25% in females,
which increased further to 25% and 30% respectively by
2013 (Fig. 2). These represent absolute increases of 18–
23% points or 3 to 5-fold to increases. Over 1981–2004
the proportion of circulatory disease mortality rose from
44% to 48% in males, and from 45% to 54% in females.
In 2005, circulatory disease mortality proportions fell pre-
cipitously to 37% for males and 40% for females, followed
by slower declines to 31% (males) and 34% (females) by
2013. These declines represented absolute decreases of
11–14% points, and proportionate declines of 24% and
26%, respectively, over 2004–2005. ICD–10 coding was
introduced in Mauritius in 2005.
In Fiji, sharp rises in proportional diabetes mortality
from 3% in both sexes in 2001 to 15% in males and 20%
in females 2002 were followed by more gradual trend
increases to 20% (males) and 27% (females) by 2012–13
(Fig. 3). These represented absolute increases of
17–25% points or 6 to 9-fold increases. Circulatory
disease proportions fell steeply from 58% in males and
53% in females in 2001 to 44% and 38% respectively by
2004, with subsequent more gradual declines to 39%
and 30% respectively by 2012–13. The absolute decrease
Fig. 1 Proportions of total mortality (%) from diabetes and circulatory disease, by sex, Australia 1980–2015
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Fig. 2 Proportions of total mortality (%) from diabetes and circulatory disease, by sex, Mauritius 1981–2016
was 19–23% points, representing corresponding 33–43%
proportionate declines. WHO mortality data was coded
according to ICD–10 in 2001, but effects attributable to
the coding changeover did not manifest until 2002.
Averaged for both sexes, in both Mauritius and Fiji fol-
lowing the cause-of-death coding change, proportional
mortality from diabetes increased from around 5% to 25%
(five-fold increase of 20% points), and circulatory dis-
ease mortality declined by approximately 20% points from
around 55% to 35% (36% proportional decline).
Discussion
The World Life Expectancy website indicates that Mauri-
tius and Fiji have the highest death rates from diabetes in
the world, and in July 2016 an article appeared in the Fiji
Times Online reporting that Fiji had the second highest
diabetes mortality rate in the world, exceeded only by
Mauritius [11].
The present study has taken a closer look at diabetes and
circulatory disease proportional mortality trends in the
two countries, from publicly available cause-specific mor-
tality data accessible fromWHO, [10] and has shown that
these high levels appear to have stemmed from changes
in cause-of-death coding practices. Three to five-fold
increases in diabetes proportional mortality occurred in
Mauritius concurrently with the change from ICD–9 to
ICD–10 cause-of-death coding in 2005. In Fiji the increase
was 6-9 fold which occurred more gradually. Circulatory
disease proportional mortality showed inverse patterns
that were similar: a sudden 24%–26% decrease in Mauri-
tius in 2005, and amore gradual decrease in Fiji of 33–43%
over 2001–2012. The changed CVD and diabetes mortal-
ity levels have continued thereafter in each country. These
changes exceed by a wide margin the relatively minor
changes found in bridge-coding studies from developed
countries.
Mortality data are reported routinely by member coun-
tries to the WHO mortality database, [10] and cause of
death supplied is the underlying cause of death. Underly-
ing cause of death is extracted and coded from the death
certification as part of routine mortality processing and
vital registration in the source country.
Available information from the Ministry of Health
indicates that in Fiji, ICD–10 coding was first introduced
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Fig. 3 Proportions of total mortality (%) from diabetes and circulatory disease, by sex, Fiji 2001–2012
in 1999 but was not fully implemented with respect to
cause-of-death coding until after 2001. Despite this, the
WHO mortality data for Fiji (as supplied to WHO by the
Fiji Ministry of Health) are coded according to ICD–9
protocols up to 2000. The more graduated implementa-
tion of ICD–10 coding explains the more gradual change
in the mortality trends compared to Mauritius. How-
ever, lack of reliable mortality data for Fiji in the WHO
database from before the introduction of ICD–10 pre-
cluded assessment of proportionalmortality from this ear-
lier period. Nonetheless, secular trends from 2001 clearly
show increasing diabetes and reciprocal decreasing circu-
latory disease proportional mortality of a broadly similar
pattern and magnitude to that of Mauritius.
Examining trends in cause-specific proportional mor-
tality is always fraught because such trends are not inde-
pendent of changing contributions to overall mortality
from other unrelated causes. However, in this instance
the magnitude of the increase in proportional mortality
from diabetes quite closely matches the magnitude and
timing of reduction in cardiovascular proportional mor-
tality. Notable also that during the study period, trends
in all-cause mortality rates and life expectancy at birth
were stable in Fiji, [12–14] and trends in life expectancy
at birth and mortality from non-communicable disease in
Mauritius were also stable [15, 16].
These trends contrast with Australia where diabetes and
circulatory disease mortality trends prior to and after the
introduction of ICD–10 coding in 1998 remained largely
unaffected, as demonstrated also in the present analysis,
and as documented by the Australian Institute of Health
and Welfare report for 1981–2011 [17]. A stable trend
of around 20/105 male age-standardised diabetes mortal-
ity (as underlying cause), and around 13/105 for females,
occurred over 1981–2011. For ‘diabetes associated’ mor-
tality - diabetes in Part I or Part II of the of the death
certificate (DC) - rates were 70/105 for males and 45/105
for females. The changes also contrast markedly with the
US and European bridge-coding studies, [3, 4] where the
highest ICD–9 to ICD–10 related change reported was a
20% proportionate elevation in diabetes mortality in the
Netherlands [4]. In other words, changes related to ICD–
9 to ICD–10 mortality coding mostly have been minor in
the (developed) countries studied.
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Considerable variation in placing and sequencing causes
of death on DCs in the presence of diabetes has been
found. For example, a 1991 Dutch study of 228 physi-
cians, who each compiled DCs from six case histories,
found significant variation in assignment of underlying
cause of death when diabetes was present [18]. Certifier
education and changes in death certification and coding
practices were recommended as remedies for misclassi-
fying underlying cause of death. Numerous other studies
have focussed on the sources of physician variation in cer-
tification practices, including incorrect cause sequencing
and multiple causes inserted into single lines [19]. A com-
mon finding was of hypertension frequently placed below
diabetes in the Part I DC causal sequence, implying that
hypertension was a cause of diabetes [20].
Diabetes can be a direct cause of death, and appear
in Part I of the DC, when a consequence of a specific
diabetes complication covered by ICD–10 codes E10.0–
8, E11.0–8, E14.0–8. When diabetes acts as a risk fac-
tor, usually along with several others, then it is properly
placed in Part II of the death certificate as a signifi-
cant condition which contributes to death, but does not
directly cause it. Atherosclerotic vascular disease can lead
directly to death especially through coronary artery dis-
ease, includingmyocardial infarction, and cerebrovascular
disease (‘stroke’), and is a consequence of several inter-
acting (modifiable) risk factors, especially high levels of
blood pressure and plasma cholesterol (related to obesity,
diet, exercise etc.), and tobacco smoking. Diabetes is also
a risk factor for atherosclerotic vascular disease, and if
cardiac or cerebrovascular disease is the cause of death,
then uncomplicated diabetes (if listed) is properly placed
in Part II of the DC by the certifier, along with other risk
factors for circulatory disease.
The problem appears to be more fundamental than
incorrect placement and sequencing of diabetes in DCs.
There are no complication categories under diabetes
in the ICD–10 code set for coronary heart disease or
myocardial infarction, or for cerebrovascular disease or
stroke (thrombosis or haemorrhage); these are all in the
Circulatory Disease ICD–10 Chapter. Thus ICD coding is
congruent with medical understanding, and death certifi-
cation practice in most countries. However, according to
the ICD–10 coding instruction manual, under ‘Accepted
sequences’ (Section k, p.58), [21] ‘Acute or terminal cir-
culatory diseases due to other conditions’, is the following
instruction: ‘Accept the following acute or terminal cir-
culatory diseases as due to malignant neoplasm, diabetes
or asthma:’, and the list of conditions comprises: numer-
ous cardiac and cerebrovascular conditions (Table 1). The
mechanical application of this rule necessarily will result
inmisclassification of circulatory disease death as diabetes
as the underlying cause of death when diabetes without
(lethal) complications is placed (inappropriately) in Part I
Table 1 Extra-diabetes cause-of-death sequences overridden by
diabetes as underlying cause of death under ICD–10 coding rules
Condition ICD–10 code
Acute and subsequent myocardial infarction I21, I22
Other acute ischaemic heart disease I24
Pulmonary embolism I26
Acute pericarditis I30
Acute and subacute endocarditis I33
Acute myocarditis I40
Atrioventricular and left bundle-branch block I44
Other conduction disorders I45
Cardiac arrest I46
Paroxysmal tachycardia I47
Atrial fibrillation and flutter I48
Other cardiac arrhythmias I49
Heart failure I50
Other ill-defined heart diseases I51.8
Cerebrovascular diseases I60–I66,
I67.6–8,
I69
of the DC. Notably, the provisions above under ICD–10
instructions, Section k had no counterpart in ICD–9, and
are entirely new. Previously under ICD–9, when diabetes
‘not otherwise specified’ or in the absence of a lethal com-
plication (such as renal insufficiency) was in Part I of the
DC alongside acute cardiovascular conditions, diabetes
may have been ignored or moved to Part II by the med-
ical coders; under ICD–10, the instructions are to retain
diabetes in Part I and for it to take priority over other
causes excepting cancer or external cause (e.g., death from
trauma).
In both Mauritius and Fiji, the dramatic changes in
diabetes and circulatory disease mortality appear to be
related in time to the introduction of ICD version 10, at
first abruptly (70–80% of the recorded increase/decrease
in the first year), then progressively in each country.
This is most likely a consequence of changes in oper-
ationalisaton of selection of underlying cause of death
under ICD–10 in these countries. It might be argued that
an increase in the frequency of uncomplicated diabetes
appearing in Part I of death certificates in both Mauri-
tius and Fiji has occurred as a consequence of undoubted
rise in diabetes prevalence in both countries accompa-
nying increased blood glucose testing as part of health
care, [22–25] especially using portable glucose meters.
However, the suddenness and magnitude of the increases
in proportional diabetes mortality coinciding with the
change to ICD–10 mortality coding renders this expla-
nation implausible for the short term changes, but may
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contribute to later increasing trends. Without appropriate
pre-processing of death certificate data, the introduction
of automated mortality coding from DCs (eg, IRIS soft-
ware[26]) likely will entrench this situation of artefactually
raised diabetes mortality and lowered circulatory disease
mortality.
From a Mauritius study of mortality outcomes in an
adult cohort (aged 20–82 years, n = 9559) followed from
1987 to 2007 (median follow-up time 15 years), [27] Circu-
latory disease mortality comprised 54% of total mortality
in the cohort, when counting cardiac mortality (38%),
cerebrovascular mortality (15%) and death from compli-
cations of hypertension (1%) as death from ‘circulatory
disease’. Underlying cause of death was coded by the study
physicians with veracity of a sub-sample of DCs checked
against a random sample (n = 400) of corresponding hos-
pital records. From the WHO death data, approximately
5% of all mortality in Mauritius comes from those aged <
20 years for 2000–14, and accounting for< 20 year deaths,
this cohort estimate of the circulatory disease mortality
proportion becomes 52% for all ages, which is close to the
proportion for males and females together under ICD–9
mortality coding for this period (Fig. 2).
In Fiji, from cause-specific mortality data reported from
a representative cohort study of adults (n = 2546)
followed from 1980 to 1991, [28] we estimate the pro-
portional mortality from diabetes to be 5.9% and 6.3%,
males and females respectively for the 11–year period,
somewhat higher than proportions for 2001 (cf. Fig. 3)
but substantially lower than those reported for 2009–12
(16%–20%, M; 25%–27%, F). Corresponding proportional
mortality from circulatory disease is estimated as 52.8%
and 49.3% from the 1980-91 cohort study, [28] somewhat
lower than for 2001 but considerably higher than over
2009–12 (40%–46%, M; 30%–39%, F).
The findings from these Mauritius and Fiji cohort
studies, involving detailed cause-of-death assessment, are
more in accord with those from ICD–9 routine coding
rather than with those from ICD–10 routine coding.
At face value, the simultaneous rise in diabetesmortality
and decline in circulatory disease mortality has attracted
no obvious attention nor proffered explanations. These
sudden changes cannot be explained by corresponding
sudden and opposing nation-level changes in risk factors
and their interactions for each mortality outcome. In Fiji,
smoking prevalence has declined over the long term, but
the decline has not been marked from 2000, [29] and thus
changes in smoking prevalence are not a candidate for
explaining the apparent sudden drop in circulatory disease
mortality in Fiji. Prevalence of hypertension, the other
major risk factor for circulatory disease mortality, has
increased consistently in Fiji since the 1980s, [30] and thus
the increases in this risk factor cannot explain the appar-
ent sudden drop in circulatory disease mortality. Obesity
prevalence in Fiji has increased substantially over the last
30 years, with corresponding increases in diabetes preva-
lence [24]. However, expected mortality outcomes might
be increased diabetes mortality and increased circulatory
disease mortality (not declines). Trends in prevalence of
CVD and diabetes risk factors are not congruent with
trends in diabetes and circulatory disease mortality in Fiji.
In the Global Health Estimates Summary Tables for
2011, [9] WHO categorises mortality data from Mau-
ritius as “Reasonably complete death registration data
available with underlying cause of death coded using
ICD–9 or ICD–10 without excessive use of inappropri-
ate or non-specific codes”; mortality from Fiji is rated as
“Data have low completeness and/or issues with cause-of-
death assignment which likely affect estimated deaths by
cause and time trends” [9]. The examples ofMauritius and
Fiji indicate that “excessive use of inappropriate or non-
specific codes” is occurring under the aegis of the ICD–10
coding regime.
In Australia and other developed countries, changes
in proportional diabetes mortality are not so apparent,
but nonetheless are present. A 2010 study by one of the
authors (CR) showed the 1999–2006 trend of diabetes
proportional mortality (i.e., as underlying cause of death)
to increase from 2.3% to 2.7% [31]. Over the same period,
there was a minor increase in the proportion of these dia-
betes deaths comprising diabetes without complications
from 74.3% to 77.6%. Further, the proportion of diabetes
as underlying CoD, with CVD also in Part I of the DC,
increased from 1.6% to 2.1% of all deaths; and the pro-
portion of these diabetes deaths without complication
increased from 70.0% to 75.2%. In other words, despite
low absolute proportions, around three quarters of dia-
betes as underlying cause of death arises from ‘diabetes
without complications’. This is not isolated to Australia, as
the authors found similar results for the US [31]. This sit-
uation appears to reflect an increasing trend of medical
certifiers to place diabetes in Part I of the DC, combined
with ICD–10 coding instructions that prevent removal
of ‘uncomplicated diabetes’ from Part I of the DC. In
some cases, if ‘uncomplicated diabetes’ is accompanied by
chronic renal insufficiency (unspecified) in Part I of the
death certificate, an inference may be drawn that the renal
disease is a consequence of diabetes. As is evident for
Australia and USA, the absolute magnitude of changes in
proportional mortality from diabetes and circulatory dis-
eases associated with changes in ICD coding practice were
far less than those documented in Mauritius and Fiji.
Errors in placement and sequencing of causes of death
at certification could be corrected by experienced manual
coders or by pre-processing digitised DCs before appli-
cation of automated cause-of-death coding software such
as IRIS [26]. In many less developed countries, Part II
of the death certificate is infrequently used (≤ 5%), and
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contributory conditions may be placed in Part I of the DC
where, according to ICD–10 rules, they are considered as
conditions that lead directly to death for the purpose of
determination of the underlying cause of death. Thus ‘dia-
betes without complications’ (E10.9, E11.9, E14.9 in ICD–
10) or ‘diabetes, not otherwise specified’, when placed in
Part I of the DC will usually become the underlying cause
of death, as indicated by the ICD–10 instructions quoted
above. The only conditions that override this stipulation
are cancer or external cause (injury). Thus coronary heart
disease or stroke will not appear as the underlying cause
of death when accompanied by uncomplicated diabetes in
Part I of the DC since cardiovascular disease is considered
as a sequel to diabetes, but diabetes is not a consequence
of CVD. However, CVD in diabetics is usually a sequel to
other interacting risk factors in addition to diabetes.
A strength of the present study is that it uses whole-
population cause-specific mortality data that extends over
periods that span changes in cause-of-death coding, and
these changes are shown to be quite marked in the case of
Fiji and particularly Mauritius. A weakness of the study is
that multiple causes of death were not available from the
original data assembled from death certificates to enable
more detailed analysis at an individual level.
Conclusions
Large, abrupt changes in diabetes and circulatory disease
proportional mortality in Fiji and Mauritius coincided
with the local introduction of ICD–10 coding in different
years. Diabetes is not nearly as large a contributor to the
mortality profiles ofMauritius and Fiji as indicated by offi-
cial mortality statistics. The progressive replacement of
circulatory disease mortality by diabetes mortality implies
that cardiovascular disease, the major cause of prema-
ture mortality, is decreasing (improving). We have shown
that these trends are likely fallacious and bear no plau-
sible relation to trends in population risk factors. These
artefacts can undermine accurate monitoring of cause of
death for evaluation of effectiveness of prevention and
control, especially of circulatory disease mortality which
is demonstrably reversible in populations.
Accurate assessment of cardiovascular disease and dia-
betes mortality is essential for assessing the magnitude of
premature mortality at a population level, and of the suc-
cess or otherwise of actions to prevent and control the
diversity of modifiable risk factors and treatment. Action
is required to change coding instructions in ICD–10 to
prevent such coding artefacts recurring, particularly in
developing countries where death certification errors are
frequent. International guidelines for recording diabetes
in death certification are needed, [32] and recommen-
dations for changes in ICD–10 rules for coding under-
lying cause of death in the presence of diabetes on the
death certificate have been formulated [33].Mortality data
already recorded and based on digitised death certifi-
cates with multiple causes of death can be pre-processed
to shift ‘diabetes with no lethal diabetes complication’
from Part I to Part II of the death certificate prior to
automated re-coding with software such as IRIS. Prospec-
tively, improved information and training is needed for
certifying physicians (and medical students) concerning
circumstances when diabetes should be placed in Part I or
Part II of the death certificate.
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